{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "32239870", "DateCompleted": {"Year": "2021", "Month": "10", "Day": "26"}, "DateRevised": {"Year": "2023", "Month": "08", "Day": "17"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": ["192, Part 2", "Res Rep Health Eff Inst. 2020 Mar;(192, Pt 2):1-90."], "Journal": {"ISSN": "1041-5505", "JournalIssue": {"Volume": "2020", "Issue": "192, Pt 2", "PubDate": {"Year": "2020", "Month": "Mar"}}, "Title": "Research report (Health Effects Institute)", "ISOAbbreviation": "Res Rep Health Eff Inst"}, "ArticleTitle": "Multicenter Ozone Study in oldEr Subjects (MOSES): Part 2. Effects of Personal and Ambient Concentrations of Ozone and Other Pollutants on Cardiovascular and Pulmonary Function.", "Pagination": {"StartPage": "1", "EndPage": "90", "MedlinePgn": "1-90"}, "Abstract": {"AbstractText": ["The Multicenter Ozone Study of oldEr Subjects (MOSES) was a multi-center study evaluating whether short-term controlled exposure of older, healthy individuals to low levels of ozone (O<sub>3</sub>) induced acute changes in cardiovascular biomarkers. In MOSES Part 1 (MOSES 1), controlled O<sub>3</sub> exposure caused concentration-related reductions in lung function with evidence of airway inflammation and injury, but without convincing evidence of effects on cardiovascular function. However, subjects' prior exposures to indoor and outdoor air pollution in the few hours and days before each MOSES controlled O<sub>3</sub> exposure may have independently affected the study biomarkers and/or modified biomarker responses to the MOSES controlled O<sub>3</sub> exposures.", "MOSES 1 was conducted at three clinical centers (University of California San Francisco, University of North Carolina, and University of Rochester Medical Center) and included healthy volunteers 55 to 70 years of age. Consented participants who successfully completed the screening and training sessions were enrolled in the study. All three clinical centers adhered to common standard operating procedures and used common tracking and data forms. Each subject was scheduled to participate in a total of 11 visits: screening visit, training visit, and three sets of exposure visits consisting of the pre-exposure day, the exposure day, and the post-exposure day. After completing the pre-exposure day, subjects spent the night in a nearby hotel. On exposure days, the subjects were exposed for 3 hours in random order to 0 ppb O<sub>3</sub> (clean air), 70 ppb O<sub>3</sub>, and 120 ppm O<sub>3</sub>. During the exposure period the subjects alternated between 15 minutes of moderate exercise and 15 minutes of rest. A suite of cardiovascular and pulmonary endpoints was measured on the day before, the day of, and up to 22 hours after each exposure.", "In MOSES Part 2 (MOSES 2), we used a longitudinal panel study design, cardiopulmonary biomarker data from MOSES 1, passive cumulative personal exposure samples (PES) of O<sub>3</sub> and nitrogen dioxide (NO<sub>2</sub>) in the 72 hours before the pre-exposure visit, and hourly ambient air pollution and weather measurements in the 96 hours before the pre-exposure visit. We used mixed-effects linear regression and evaluated whether PES O<sub>3</sub> and NO<sub>2</sub> and these ambient pollutant concentrations in the 96 hours before the pre-exposure visit confounded the MOSES 1 controlled O<sub>3</sub> exposure effects on the pre- to post-exposure biomarker changes (Aim 1), whether they modified these pre- to post-exposure biomarker responses to the controlled O<sub>3</sub> exposures (Aim 2), whether they were associated with changes in biomarkers measured at the pre-exposure visit or morning of the exposure session (Aim 3), and whether they were associated with differences in the pre- to post-exposure biomarker changes independently of the controlled O<sub>3</sub> exposures (Aim 4).", "Ambient pollutant concentrations at each site were low and were regularly below the National Ambient Air Quality Standard levels. In Aim 1, the controlled O<sub>3</sub> exposure effects on the pre- to post-exposure biomarker differences were little changed when PES or ambient pollutant concentrations in the previous 96 hours were included in the model, suggesting these were not confounders of the controlled O<sub>3</sub> exposure/biomarker difference associations. In Aim 2, effects of MOSES controlled O<sub>3</sub> exposures on forced expiratory volume in 1 second (FEV<sub>1</sub>) and forced vital capacity (FVC) were modified by ambient NO<sub>2</sub> and carbon monoxide (CO), and PES NO<sub>2</sub>, with reductions in FEV<sub>1</sub> and FVC observed only when these concentrations were \"Medium\" or \"High\" in the 72 hours before the pre-exposure visit. There was no such effect modification of the effect of controlled O<sub>3</sub> exposure on any other cardiopulmonary biomarker.", "As hypothesized for Aim 3, increased ambient O<sub>3</sub> concentrations were associated with decreased pre-exposure heart rate variability (HRV). For example, high frequency (HF) HRV decreased in association with increased ambient O<sub>3</sub> concentrations in the 96 hours before the pre-exposure visit (-0.460 ln[ms<sup>2</sup>]; 95% CI, -0.743 to -0.177 for each 10.35-ppb increase in O<sub>3</sub>; <i>P</i> = 0.002). However, in Aim 4 these increases in ambient O<sub>3</sub> were also associated with increases in HF and low frequency (LF) HRV from pre- to post-exposure, likely reflecting a \"recovery\" of HRV during the MOSES O<sub>3</sub> exposure sessions. Similar patterns across Aims 3 and 4 were observed for LF (the other primary HRV marker), and standard deviation of normal-to-normal sinus beat intervals (SDNN) and root mean square of successive differences in normal-to-normal sinus beat intervals (RMSSD) (secondary HRV markers).", "Similar Aim 3 and Aim 4 patterns were observed for FEV<sub>1</sub> and FVC in association with increases in ambient PM with an aerodynamic diameter \u2264 2.5 \u03bcm (PM<sub>2.5</sub>), CO, and NO<sub>2</sub> in the 96 hours before the pre-exposure visit. For Aim 3, small decreases in pre-exposure FEV<sub>1</sub> were significantly associated with interquartile range (IQR) increases in PM<sub>2.5</sub> concentrations in the 1 hour before the pre-exposure visit (-0.022 L; 95% CI, -0.037 to -0.006; <i>P</i> = 0.007), CO in the 3 hours before the pre-exposure visit (-0.046 L; 95% CI, -0.076 to -0.016; <i>P</i> = 0.003), and NO<sub>2</sub> in the 72 hours before the pre-exposure visit (-0.030 L; 95% CI, -0.052 to -0.008; <i>P</i> = 0.007). However, FEV<sub>1</sub> was not associated with ambient O<sub>3</sub> or sulfur dioxide (SO<sub>2</sub>), or PES O<sub>3</sub> or NO<sub>2</sub> (Aim 3). For Aim 4, increased FEV<sub>1</sub> across the exposure session (post-exposure minus pre-exposure) was marginally significantly associated with each 4.1-ppb increase in PES O<sub>3</sub> concentration (0.010 L; 95% CI, 0.004 to 0.026; <i>P</i> = 0.010), as well as ambient PM<sub>2.5</sub> and CO at all lag times. FVC showed similar associations, with patterns of decreased pre-exposure FVC associated with increased PM<sub>2.5</sub>, CO, and NO<sub>2</sub> at most lag times, and increased FVC across the exposure session also associated with increased concentrations of the same pollutants, reflecting a similar recovery. However, increased pollutant concentrations were not associated with adverse changes in pre-exposure levels or pre- to post-exposure changes in biomarkers of cardiac repolarization, ST segment, vascular function, nitrotyrosine as a measure of oxidative stress, prothrombotic state, systemic inflammation, lung injury, or sputum polymorphonuclear leukocyte (PMN) percentage as a measure of airway inflammation.", "Our previous MOSES 1 findings of controlled O<sub>3</sub> exposure effects on pulmonary function, but not on any cardiovascular biomarker, were not confounded by ambient or personal O<sub>3</sub> or other pollutant exposures in the 96 and 72 hours before the pre-exposure visit. Further, these MOSES 1 O<sub>3</sub> effects were generally not modified, blunted, or lessened by these same ambient and personal pollutant exposures. However, the reductions in markers of pulmonary function by the MOSES 1 controlled O<sub>3</sub> exposure were modified by ambient NO<sub>2</sub> and CO, and PES NO<sub>2</sub>, with reductions observed only when these pollutant concentrations were elevated in the few hours and days before the pre-exposure visit. Increased ambient O<sub>3</sub> concentrations were associated with reduced HRV, with \"recovery\" during exposure visits. Increased ambient PM<sub>2.5</sub>, NO<sub>2</sub>, and CO were associated with reduced pulmonary function, independent of the MOSES-controlled O<sub>3</sub> exposures. Increased pollutant concentrations were not associated with pre-exposure or pre- to post-exposure changes in other cardiopulmonary biomarkers. Future controlled exposure studies should consider the effect of ambient pollutants on pre-exposure biomarker levels and whether ambient pollutants modify any health response to a controlled pollutant exposure."], "CopyrightInformation": "\u00a9 2020 Health Effects Institute. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "University of Rochester Medical Center, Rochester, New York."}], "LastName": "Rich", "ForeName": "D Q", "Initials": "DQ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "University of Rochester Medical Center, Rochester, New York."}], "LastName": "Frampton", "ForeName": "M W", "Initials": "MW"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "University of California at San Francisco."}], "LastName": "Balmes", "ForeName": "J R", "Initials": "JR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "University of North Carolina at Chapel Hill."}], "LastName": "Bromberg", "ForeName": "P A", "Initials": "PA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "University of California at San Francisco."}], "LastName": "Arjomandi", "ForeName": "M", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "University of North Carolina at Chapel Hill."}], "LastName": "Hazucha", "ForeName": "M J", "Initials": "MJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "University of Rochester Medical Center, Rochester, New York."}], "LastName": "Thurston", "ForeName": "S W", "Initials": "SW"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "University of North Carolina at Chapel Hill."}], "LastName": "Alexis", "ForeName": "N E", "Initials": "NE"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "University of California at San Francisco."}], "LastName": "Ganz", "ForeName": "P", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "University of Rochester Medical Center, Rochester, New York."}], "LastName": "Zareba", "ForeName": "W", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Harvard T.H. Chan School of Public Health, Boston, Massachusetts."}], "LastName": "Koutrakis", "ForeName": "P", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "University of Rochester Medical Center, Rochester, New York."}], "LastName": "Thevenet-Morrison", "ForeName": "K", "Initials": "K"}], "PublicationTypeList": ["Journal Article", "Multicenter Study", "Research Support, Non-U.S. Gov't", "Research Support, U.S. Gov't, Non-P.H.S.", "Technical Report"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Res Rep Health Eff Inst", "NlmUniqueID": "8812230", "ISSNLinking": "1041-5505"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Air Pollutants"}, {"RegistryNumber": "0", "NameOfSubstance": "Biomarkers"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "9007-41-4", "NameOfSubstance": "C-Reactive Protein"}, {"RegistryNumber": "S7G510RUBH", "NameOfSubstance": "Nitrogen Dioxide"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Aged"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Air Pollutants"}, {"QualifierName": [], "DescriptorName": "Biomarkers"}, {"QualifierName": ["drug effects"], "DescriptorName": "C-Reactive Protein"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cardiovascular System"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Nitrogen Dioxide"}, {"QualifierName": ["physiology"], "DescriptorName": "Oxidative Stress"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Ozone"}, {"QualifierName": [], "DescriptorName": "Respiratory Function Tests"}, {"QualifierName": ["drug effects"], "DescriptorName": "Respiratory System"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Alexeeff SE, Litonjua AA, Suh H, Sparrow D, Vokonas PS, Schwartz J. 2007. Ozone exposure and lung function: Effect modified by obesity and airways hyperresponsiveness in the VA normative aging study. Chest 132:1890\u20131897.", "ArticleIdList": ["17925423"]}, {"Citation": "Arjomandi M, Balmes JR, Frampton MW, Bromberg P, Rich DQ, Stark P, et al. 2018. Respiratory responses to ozone exposure. MOSES (the Multicenter Ozone Study in oldEr Subjects). Am J Respir Crit Care Med 197:1319\u20131327.", "ArticleIdList": ["29232153"]}, {"Citation": "Arjomandi M, Wong H, Donde A, Frelinger J, Dalton S, Ching W, et al. 2015. Exposure to medium and high ambient levels of ozone causes adverse systemic inflammatory and cardiac autonomic effects. Am J Physiol Heart Circ Physiol 308:H1499\u20131509.", "ArticleIdList": ["PMC4469877", "25862833"]}, {"Citation": "Ballester F, Rodriguez P, Iniguez C, Saez M, Daponte A, Galan I, et al. 2006. Air pollution and cardiovascular admissions association in Spain: Results within the EMECAS project. J Epidemiol Community Health 60:328\u2013336.", "ArticleIdList": ["PMC2566168", "16537350"]}, {"Citation": "Balmes JR, Arjomandi M, Bromberg PA, Costantini MG, Dagincourt N, Hazucha MJ, et al. 2019. Ozone effects on blood biomarkers of systemic inflammation, oxidative stress, endothelial function, and thrombosis: The Multicenter Ozone Study in oldEr Subjects (MOSES). PLoS One. 14(9):e0222601 doi: 10.1371/journal.pone.0222601.", "ArticleIdList": ["PMC6760801", "31553765"]}, {"Citation": "Barath S, Langrish JP, Lundback M, Bosson JA, Goudie C, Newby DE, et al. 2013. Short-term exposure to ozone does not impair vascular function or affect heart rate variability in healthy young men. Toxicol Sci 135:292\u2013299.", "ArticleIdList": ["PMC3807622", "23872581"]}, {"Citation": "Barnett AG, Williams GM, Schwartz J, Best TL, Neller AH, Petroeschevsky AL, et al. 2006. The effects of air pollution on hospitalizations for cardiovascular disease in elderly people in Australian and New Zealand Cities. Environ Health Perspect 114:1018\u20131023.", "ArticleIdList": ["PMC1513338", "16835053"]}, {"Citation": "Bartell SM, Longhurst J, Tjoa T, Sioutas C, Delfino RJ. 2013. Particulate air pollution, ambulatory heart rate variability, and cardiac arrhythmia in retirement community residents with coronary artery disease. Environ Health Perspect 121:1135\u20131141.", "ArticleIdList": ["PMC3801451", "23838152"]}, {"Citation": "Bateson TF, Coull BA, Hubbell B, Ito K, Jerrett M, Lumley T, et al. 2007. Panel discussion review: Session three \u2014 issues involved in interpretation of epidemiologic analyses \u2014 statistical modeling. J Expo Sci Environ Epidemiol 17 Suppl 2:S90\u201396.", "ArticleIdList": ["18079770"]}, {"Citation": "Bravo MA, Son J, de Freitas CU, Gouveia N, Bell ML. 2016. Air pollution and mortality in S\u00e3o Paulo, Brazil: effects of multiple pollutants and analysis of susceptible populations. J Expo Sci Environ Epidemiol 26(2):150\u2013161.", "ArticleIdList": ["25586330"]}, {"Citation": "Bedi JF, Horvath SM, Drechsler-Parks DM. 1988. Reproducibility of the pulmonary function response of older men and women to a 2-hour ozone exposure. JAPCA 38:1016\u20131019.", "ArticleIdList": ["3221255"]}, {"Citation": "Bedi JF, Horvath SM, Drechsler-Parks DM. 1989. Adaptation by older individuals repeatedly exposed to 0.45 parts per million ozone for two hours. JAPCA 39:194\u2013199.", "ArticleIdList": ["2715788"]}, {"Citation": "Bell ML, McDermott A, Zeger SL, Samet JM, Dominici F. 2004. Ozone and short-term mortality in 95 US urban communities, 1987\u20132000. JAMA 292:2372\u20132378.", "ArticleIdList": ["PMC3546819", "15547165"]}, {"Citation": "Br\u00e4uner EV, Forchhammer L, Moller P, Barregard L, Gunnarsen L, Afshari A, et al. 2008. Indoor particles affect vascular function in the aged: An air filtration-based intervention study. Am J Respir Crit Care Med 177:419\u2013425.", "ArticleIdList": ["17932377"]}, {"Citation": "Bromberg PA. 2016. Mechanisms of the acute effects of inhaled ozone in humans. Biochim Biophys Acta 1860:2771\u20132781.", "ArticleIdList": ["27451958"]}, {"Citation": "Brook RD, Brook JR, Urch B, Vincent R, Rajagopalan S, Silverman F. 2002. Inhalation of fine particulate air pollution and ozone causes acute arterial vasoconstriction in healthy adults. Circulation 105:1534\u20131536.", "ArticleIdList": ["11927516"]}, {"Citation": "Brook RD, Urch B, Dvonch JT, Bard RL, Speck M, Keeler G, et al. 2009. Insights into the mechanisms and mediators of the effects of air pollution exposure on blood pressure and vascular function in healthy humans. Hypertension 54:659\u2013667.", "ArticleIdList": ["PMC3706996", "19620518"]}, {"Citation": "Buteau S, Goldberg MS. 2015. Methodological issues related to pooling results from panel studies of heart rate variability and its association with ambient air pollution. Environ Res 140:462\u2013465.", "ArticleIdList": ["25984645"]}, {"Citation": "Buteau S, Goldberg MS, Burnett RT, Gasparrini A, Valois MF, Brophy JM, et al. 2018. Associations between ambient air pollution and daily mortality in a cohort of congestive heart failure: Case-crossover and nested case-control analyses using a distributed lag nonlinear model. Environ Int 113:313\u2013324.", "ArticleIdList": ["29361317"]}, {"Citation": "Chan CC, Chuang KJ, Chien LC, Chen WJ, Chang WT. 2006. Urban air pollution and emergency admissions for cerebrovascular diseases in Taipei, Taiwan. Eur Heart J 27:1238\u20131244.", "ArticleIdList": ["16537554"]}, {"Citation": "Chang CC, Tsai SS, Ho SC, Yang CY. 2005. Air pollution and hospital admissions for cardiovascular disease in Taipei, Taiwan. Environ Res 98:114\u2013119.", "ArticleIdList": ["15721891"]}, {"Citation": "Chen R, Zhao A, Chen H, Zhao Z, Cai J, Wang C, et al. 2015. Cardiopulmonary benefits of reducing indoor particles of outdoor origin: A randomized, double-blind crossover trial of air purifiers. J Am Coll Cardiol 65:2279\u20132287.", "ArticleIdList": ["PMC5360574", "26022815"]}, {"Citation": "Chuang KJ, Chan CC, Su TC, Lee CT, Tang CS. 2007. The effect of urban air pollution on inflammation, oxidative stress, coagulation, and autonomic dysfunction in young adults. Am J Respir Crit Care Med 176:370\u2013376.", "ArticleIdList": ["17463411"]}, {"Citation": "Coogan PF, White LF, Yu J, Brook RD, Burnett RT, Marshall JD, et al. 2017. Long-term exposure to NO2 and ozone and hypertension incidence in the black women\u2019s health study. Am J Hypertens 30:367\u2013372.", "ArticleIdList": ["PMC5861564", "28096146"]}, {"Citation": "Corea F, Silvestrelli G, Baccarelli A, Giua A, Previdi P, Siliprandi G, et al. 2012. Airborne pollutants and lacunar stroke: A case cross-over analysis on stroke unit admissions. Neurol Int 4:e11.", "ArticleIdList": ["PMC3490470", "23139849"]}, {"Citation": "Devlin RB, Duncan KE, Jardim M, Schmitt MT, Rappold AG, Diaz-Sanchez D. 2012. Controlled exposure of healthy young volunteers to ozone causes cardiovascular effects. Circulation 126:104\u2013111.", "ArticleIdList": ["22732313"]}, {"Citation": "Devlin RB, McDonnell WF, Mann R, Becker S, House DE, Schreinemachers D, et al. 1991. Exposure of humans to ambient levels of ozone for 6.6 hours causes cellular and biochemical changes in the lung. Am J Respir Cell Mol Biol 4:72\u201381.", "ArticleIdList": ["1846079"]}, {"Citation": "Di Q, Dai L, Wang Y, Zanobetti A, Choirat C, Schwartz JD, et al. 2017. Association of short-term exposure to air pollution with mortality in older adults. JAMA 318:2446\u20132456.", "ArticleIdList": ["PMC5783186", "29279932"]}, {"Citation": "Drechsler-Parks DM, Bedi JF, Horvath SM. 1987. Pulmonary function responses of older men and women to ozone exposure. Exp Gerontol 22:91\u2013101.", "ArticleIdList": ["3622653"]}, {"Citation": "Drechsler-Parks DM, Bedi JF, Horvath SM. 1989. Pulmonary function responses of young and older adults to mixtures of O3, NO2 and PAN. Toxicol Ind Health 5:505\u2013517.", "ArticleIdList": ["2763312"]}, {"Citation": "Drechsler-Parks DM, Horvath SM, Bedi JF. 1990. The \u201ceffective dose\u201d concept in older adults exposed to ozone. Exp Gerontol 25:107\u2013115.", "ArticleIdList": ["2369925"]}, {"Citation": "Evans KA, Hopke PK, Utell MJ, Kane C, Thurston SW, Ling FS, et al. 2016. Triggering of ST-elevation myocardial infarction by ambient wood smoke and other particulate and gaseous pollutants. J Expo Sci Environ Epidemiol. 27:198\u2013206; doi:10.1038/jes.2016.15.", "ArticleIdList": ["PMC5063679", "27072425"]}, {"Citation": "Fakhri AA, Ilic LM, Wellenius GA, Urch B, Silverman F, Gold DR, et al. 2009. Autonomic effects of controlled fine particulate exposure in young healthy adults: Effect modification by ozone. Environ Health Perspect 117:1287\u20131292.", "ArticleIdList": ["PMC2721874", "19672410"]}, {"Citation": "Frampton MW, Balmes JR, Bromberg PA, Stark P, Arjomandi M, Hazucha MJ, et al. 2017. Multicenter Ozone Study in oldEr Subjects (MOSES): Part 1. Effects of Exposure to Low Concentrations of Ozone on Respiratory and Cardiovascular Outcomes. Research Report 192, Pt 1 Boston, MA:Health Effects Institute.", "ArticleIdList": ["PMC7266375", "31898880"]}, {"Citation": "Frampton MW, Pietropaoli A, Dentler M, Chalupa D, Little EL, Stewart J, et al. 2015. Cardiovascular effects of ozone in healthy subjects with and without deletion of glutathione-S-transferase m1. Inhal Toxicol 27:113\u2013119.", "ArticleIdList": ["PMC4659648", "25600221"]}, {"Citation": "Franck U, Leitte AM, Suppan P. 2014. Multiple exposures to airborne pollutants and hospital admissions due to diseases of the circulatory system in Santiago de Chile. Sci Total Environ 468\u2013469:746\u2013756.", "ArticleIdList": ["24064344"]}, {"Citation": "Frischer T, Studnicka M, Gartner C, Tauber E, Horak F, Veiter A, et al. 1999. Lung function growth and ambient ozone: A three-year population study in school children. Am J Respir Crit Care Med 160:390\u2013396.", "ArticleIdList": ["10430703"]}, {"Citation": "Fung KY, Luginaah I, Gorey KM, Webster G. 2005. Air pollution and daily hospitalization rates for cardiovascular and respiratory diseases in London, Ontario. Int J Environ Stud 62:677\u2013685.", "ArticleIdList": ["PMC2919560", "20703387"]}, {"Citation": "Gandhi SK, Rich DQ, Ohman-Strickland PA, Kipen HM, Gow A. 2014. Plasma nitrite is an indicator of acute changes in ambient air pollutant concentrations. Inhal Toxicol 26:426\u2013434.", "ArticleIdList": ["PMC4447138", "24862977"]}, {"Citation": "Gold DR, Litonjua A, Schwartz J, Lovett E, Larson A, Nearing B, et al. 2000. Ambient pollution and heart rate variability. Circulation 101:1267\u20131273.", "ArticleIdList": ["10725286"]}, {"Citation": "Goldberg MS, Giannetti N, Burnett RT, Mayo NE, Valois MF, Brophy JM. 2008. A panel study in congestive heart failure to estimate the short-term effects from personal factors and environmental conditions on oxygen saturation and pulse rate. Occup Environ Med 65:659\u2013666.", "ArticleIdList": ["18801926"]}, {"Citation": "Gong H, Jr., McManus MS, Linn WS. 1997a. Attenuated response to repeated daily ozone exposures in asthmatic subjects. Arch Environ Health 52:34\u201341.", "ArticleIdList": ["9039855"]}, {"Citation": "Gong H, Jr., Shamoo DA, Anderson KR, Linn WS. 1997b. Responses of older men with and without chronic obstructive pulmonary disease to prolonged ozone exposure. Arch Environ Health 52:18\u201325.", "ArticleIdList": ["9039853"]}, {"Citation": "Halonen JI, Lanki T, Tiittanen P, Niemi JV, Loh M, Pekkanen J. 2010. Ozone and cause-specific cardiorespiratory morbidity and mortality. J Epidemiol Community Health 64:814\u2013820.", "ArticleIdList": ["19854743"]}, {"Citation": "Holguin F, Tellez-Rojo MM, Hernandez M, Cortez M, Chow JC, Watson JG, et al. 2003. Air pollution and heart rate variability among the elderly in Mexico City. Epidemiology 14:521\u2013527.", "ArticleIdList": ["14501266"]}, {"Citation": "Hoppe P, Peters A, Rabe G, Praml G, Lindner J, Jakobi G, et al. 2003. Environmental ozone effects in different population subgroups. Int J Hyg Environ Health 206:505\u2013516.", "ArticleIdList": ["14626898"]}, {"Citation": "Islam T, McConnell R, Gauderman WJ, Avol E, Peters JM, Gilliland FD. 2008. Ozone, oxidant defense genes, and risk of asthma during adolescence. Am J Respir Crit Care Med 177:388\u2013395.", "ArticleIdList": ["PMC2258440", "18048809"]}, {"Citation": "Jerrett M, Brook R, White LF, Burnett RT, Yu J, Su J, et al. 2017. Ambient ozone and incident diabetes: A prospective analysis in a large cohort of African American women. Environ Int 102:42\u201347.", "ArticleIdList": ["PMC5542012", "28153529"]}, {"Citation": "Jerrett M, Burnett RT, Pope CA, 3rd, Ito K, Thurston G, Krewski D, et al. 2009. Long-term ozone exposure and mortality. N Engl J Med 360:1085\u20131095.", "ArticleIdList": ["PMC4105969", "19279340"]}, {"Citation": "Jia X, Song X, Shima M, Tamura K, Deng F, Guo X. 2011. Acute effect of ambient ozone on heart rate variability in healthy elderly subjects. J Expo Sci Environ Epidemiol 21:541\u2013547.", "ArticleIdList": ["21522190"]}, {"Citation": "Kim CS, Alexis NE, Rappold AG, Kehrl H, Hazucha MJ, Lay JC, et al. 2011. Lung function and inflammatory responses in healthy young adults exposed to 0.06 ppm ozone for 6.6 hours. Am J Respir Crit Care Med 183:1215\u2013 1221.", "ArticleIdList": ["PMC3114053", "21216881"]}, {"Citation": "Lanzinger S, Breitner S, Neas L, Cascio W, Diaz-Sanchez D, Hinderliter A, et al. 2014. The impact of decreases in air temperature and increases in ozone on markers of endothelial function in individuals having type-2 diabetes. Environ Res 134:331\u2013338.", "ArticleIdList": ["25199974"]}, {"Citation": "Lee JT, Kim H, Cho YS, Hong YC, Ha EH, Park H. 2003. Air pollution and hospital admissions for ischemic heart diseases among individuals 64+ years of age residing in Seoul, Korea. Arch Environ Health 58:617\u2013623.", "ArticleIdList": ["15562633"]}, {"Citation": "Lepeule J, Bind MA, Baccarelli AA, Koutrakis P, Tarantini L, Litonjua A, et al. 2014a. Epigenetic influences on associations between air pollutants and lung function in elderly men: The normative aging study. Environ Health Perspect 122:566\u2013572.", "ArticleIdList": ["PMC4050500", "24602767"]}, {"Citation": "Lepeule J, Litonjua AA, Coull B, Koutrakis P, Sparrow D, Vokonas PS, et al. 2014b. Long-term effects of traffic particles on lung function decline in the elderly. Am J Respir Crit Care Med 190:542\u2013548.", "ArticleIdList": ["PMC4214085", "25028775"]}, {"Citation": "Link MS, Luttmann-Gibson H, Schwartz J, Mittleman MA, Wessler B, Gold DR, et al. 2013. Acute exposure to air pollution triggers atrial fibrillation. J Am Coll Cardiol 62:816\u2013825.", "ArticleIdList": ["PMC3752319", "23770178"]}, {"Citation": "Lipsett MJ, Tsai FC, Roger L, Woo M, Ostro BD. 2006. Coarse particles and heart rate variability among older adults with coronary artery disease in the Coachella Valley, California. Environ Health Perspect 114:1215\u20131220.", "ArticleIdList": ["PMC1552018", "16882528"]}, {"Citation": "McConnell R, Berhane K, Gilliland F, London SJ, Islam T, Gauderman WJ, et al. 2002. Asthma in exercising children exposed to ozone: A cohort study. Lancet 359:386\u2013391.", "ArticleIdList": ["11844508"]}, {"Citation": "McDonnell WF, Stewart PW, Smith MV, Kim CS, Schelegle ES. 2012. Prediction of lung function response for populations exposed to a wide range of ozone conditions. Inhal Toxicol 24: 619\u2013633.", "ArticleIdList": ["22906168"]}, {"Citation": "Metzger KB, Klein M, Flanders WD, Peel JL, Mulholland JA, Langberg JJ, et al. 2007. Ambient air pollution and cardiac arrhythmias in patients with implantable defibrillators. Epidemiology 18:585\u2013592.", "ArticleIdList": ["17700247"]}, {"Citation": "Mirowsky JE, Carraway MS, Dhingra R, Tong H, Neas L, Diaz-Sanchez D, et al. 2017. Ozone exposure is associated with acute changes in inflammation, fibrinolysis, and endothelial cell function in coronary artery disease patients. Environ Health 16:126.", "ArticleIdList": ["PMC5697214", "29157250"]}, {"Citation": "Mustafic H, Jabre P, Caussin C, Murad MH, Escolano S, Tafflet M, et al. 2012. Main air pollutants and myocardial infarction: A systematic review and meta-analysis. JAMA 307:713\u2013721.", "ArticleIdList": ["22337682"]}, {"Citation": "Park SK, O\u2019Neill MS, Vokonas PS, Sparrow D, Schwartz J. 2005. Effects of air pollution on heart rate variability: The VA normative aging study. Environ Health Perspect 113:304\u2013309.", "ArticleIdList": ["PMC1253756", "15743719"]}, {"Citation": "Raza A, Dahlquist M, Lind T, Ljungman PLS. 2018. Susceptibility to short-term ozone exposure and cardiovascular and respiratory mortality by previous hospitalizations. Environ Health 17:37.", "ArticleIdList": ["PMC5899411", "29653570"]}, {"Citation": "Reisenauer CS, Koenig JQ, McManus MS, Smith MS, Kusic G, Pierson WE. 1988. Pulmonary response to ozone exposures in healthy individuals aged 55 years or greater. JAPCA 38:51\u201355.", "ArticleIdList": ["3356997"]}, {"Citation": "Rice MB, Ljungman PL, Wilker EH, Gold DR, Schwartz JD, Koutrakis P, et al. 2013. Short-term exposure to air pollution and lung function in the Framingham Heart Study. Am J Respir Crit Care Med 188:1351\u20131357.", "ArticleIdList": ["PMC3919078", "24200465"]}, {"Citation": "Rich DQ, Balmes JR, Frampton MW, Zareba W, Stark P, Arjomandi M, et al. 2018. Cardiovascular function and ozone exposure: The Multicenter Ozone Study in oldEr Subjects (MOSES). Environ Int 119:193\u2013202.", "ArticleIdList": ["29980042"]}, {"Citation": "Rich DQ, Kim MH, Turner JR, Mittleman MA, Schwartz J, Catalano PJ, et al. 2006a. Association of ventricular arrhythmias detected by implantable cardioverter defibrillator and ambient air pollutants in the St Louis, Missouri metropolitan area. Occup Environ Med 63:591\u2013596.", "ArticleIdList": ["PMC2078163", "16698809"]}, {"Citation": "Rich DQ, Mittleman MA, Link MS, Schwartz J, Luttmann-Gibson H, Catalano PJ, et al. 2006b. Increased risk of paroxysmal atrial fibrillation episodes associated with acute increases in ambient air pollution. Environ Health Perspect 114:120\u2013123.", "ArticleIdList": ["PMC1332666", "16393668"]}, {"Citation": "Rich DQ, Peters A, Schneider A, Zareba W, Breitner S, Oakes D, et al. 2016. Ambient and controlled particle exposures as triggers for acute ECG-changes. Research Report 186. Health Effects Institute, Boston, MA.", "ArticleIdList": ["28661614"]}, {"Citation": "Rich DQ, Schwartz J, Mittleman MA, Link M, Luttmann-Gibson H, Catalano PJ, et al. 2005. Association of short-term ambient air pollution concentrations and ventricular arrhythmias. Am J Epidemiol 161:1123\u20131132.", "ArticleIdList": ["15937021"]}, {"Citation": "Rich KE, Petkau J, Vedal S, Brauer M. 2004. A case-crossover analysis of particulate air pollution and cardiac arrhythmia in patients with implantable cardioverter defibrillators. Inhal Toxicol 16:363\u2013372.", "ArticleIdList": ["15204752"]}, {"Citation": "Rodopoulou S, Chalbot MC, Samoli E, Dubois DW, San Filippo BD, Kavouras IG. 2014. Air pollution and hospital emergency room and admissions for cardiovascular and respiratory diseases in Dona Ana County, New Mexico. Environ Res 129:39\u201346.", "ArticleIdList": ["24529001"]}, {"Citation": "Sarnat SE, Winquist A, Schauer JJ, Turner JR, Sarnat JA. 2015. Fine particulate matter components and emergency department visits for cardiovascular and respiratory diseases in the St. Louis, Missouri\u2013Illinois, metropolitan area. Environ Health Perspect 123:437\u2013444.", "ArticleIdList": ["PMC4421761", "25575028"]}, {"Citation": "Shaffer F, Ginsberg JP. 2017. An overview of heart rate variability metrics and norms. Front Public Health 5:258.", "ArticleIdList": ["PMC5624990", "29034226"]}, {"Citation": "Shah AS, Lee KK, McAllister DA, Hunter A, Nair H, Whiteley W, et al. 2015. Short term exposure to air pollution and stroke: Systematic review and meta-analysis. BMJ 350:h1295.", "ArticleIdList": ["PMC4373601", "25810496"]}, {"Citation": "Sherazi S, Kutyifa V, McNitt S, Aktas MK, Couderc JP, Peterson B, et al. 2015. Prognostic significance of heart rate variability among patients treated with cardiac resynchronization therapy: MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy). JACC Clin Electrophysiol 1:74\u201380.", "ArticleIdList": ["29759342"]}, {"Citation": "Shields KN, Cavallari JM, Hunt MJ, Lazo M, Molina M, Molina L, et al. 2013. Traffic-related air pollution exposures and changes in heart rate variability in Mexico City: A panel study. Environ Health 12:7.", "ArticleIdList": ["PMC3639920", "23327098"]}, {"Citation": "Sivagangabalan G, Spears D, Masse S, Urch B, Brook RD, Silverman F, et al. 2011. The effect of air pollution on spatial dispersion of myocardial repolarization in healthy human volunteers. J Am Coll Cardiol 57:198\u2013206.", "ArticleIdList": ["21211691"]}, {"Citation": "Suh HH, Zanobetti A. 2010. Exposure error masks the relationship between traffic-related air pollution and heart rate variability. J Occup Environ Med 52:685\u2013692.", "ArticleIdList": ["PMC2911027", "20595912"]}, {"Citation": "Symons JM, Wang L, Guallar E, Howell E, Dominici F, Schwab M, et al. 2006. A case-crossover study of fine particulate matter air pollution and onset of congestive heart failure symptom exacerbation leading to hospitalization. Am J Epidemiol 164:421\u2013433.", "ArticleIdList": ["16793862"]}, {"Citation": "Szyszkowicz M. 2008. Ambient air pollution and daily emergency department visits for ischemic stroke in Edmonton, Canada. Int J Occup Med Environ Health 21:295\u2013300.", "ArticleIdList": ["19158072"]}, {"Citation": "Thompson AM, Zanobetti A, Silverman F, Schwartz J, Coull B, Urch B, et al. 2010. Baseline repeated measures from controlled human exposure studies: Associations between ambient air pollution exposure and the systemic inflammatory biomarkers IL-6 and fibrinogen. Environ Health Perspect 118:120\u2013124.", "ArticleIdList": ["PMC2831955", "20056584"]}, {"Citation": "Tolbert PE, Klein M, Peel JL, Sarnat SE, Sarnat JA. 2007. Multipollutant modeling issues in a study of ambient air quality and emergency department visits in Atlanta. J Expo Sci Environ Epidemiol 17 Suppl 2:S29\u201335.", "ArticleIdList": ["18079762"]}, {"Citation": "U.S. Environmental Protection Agency. 2019. \nIntegrated Science Assessment for Ozone and Related Photochemical Oxidants. First external review draft. Washington, DC:U.S. Environmental Protection Agency; \nAvailable:  https://cfpub.epa.gov/ncea/isa/recordisplay.cfm?deid=344670."}, {"Citation": "Vedal S, Rich K, Brauer M, White R, Petkau J. 2004. Air pollution and cardiac arrhythmias in patients with implantable cardioverter defibrillators. Inhal Toxicol 16:353\u2013362.", "ArticleIdList": ["15204751"]}, {"Citation": "Wheeler A, Zanobetti A, Gold DR, Schwartz J, Stone P, Suh HH. 2006. The relationship between ambient air pollution and heart rate variability differs for individuals with heart and pulmonary disease. Environ Health Perspect 114:560\u2013566.", "ArticleIdList": ["PMC1440781", "16581546"]}, {"Citation": "Wu CF, Kuo IC, Su TC, Li YR, Lin LY, Chan CC, et al. 2010. Effects of personal exposure to particulate matter and ozone on arterial stiffness and heart rate variability in healthy adults. Am J Epidemiol 171:1299\u20131309.", "ArticleIdList": ["20507901"]}, {"Citation": "Yeragani VK, Sobolewski E, Kay J, Jampala VC, Igel G. 1997. Effect of age on long-term heart rate variability. Cardiovasc Res 35:35\u201342.", "ArticleIdList": ["9302345"]}, {"Citation": "Zanobetti A, Gold DR, Stone PH, Suh HH, Schwartz J, Coull BA, et al. 2010. Reduction in heart rate variability with traffic and air pollution in patients with coronary artery disease. Environ Health Perspect 118:324\u2013330.", "ArticleIdList": ["PMC2854758", "20064780"]}, {"Citation": "Zanobetti A, Schwartz J. 2006. Air pollution and emergency admissions in Boston, MA. J Epidemiol Community Health 60:890\u2013895.", "ArticleIdList": ["PMC2566060", "16973538"]}, {"Citation": "Zeger SL, Thomas D, Dominici F, Samet JM, Schwartz J, Dockery D, et al. 2000. Exposure measurement error in time-series studies of air pollution: Concepts and consequences. Environ Health Perspect 108:419\u2013426.", "ArticleIdList": ["PMC1638034", "10811568"]}, {"Citation": "Adams WC. 2006. Comparison of chamber 6.6-h exposures to 0.04-0.08 ppm ozone via square-wave and triangular profiles on pulmonary responses. Inhal Toxicol 18(2):127\u2013136.", "ArticleIdList": ["16393927"]}, {"Citation": "Alexis NE, Lay JC, Hazucha M, Harris B, Hernandez ML, Bromberg PA, et al. 2010. Low-level ozone exposure induces airways inflammation and modifies cell surface phenotypes in healthy humans. Inhal Toxicol 22:593\u2013600.", "ArticleIdList": ["PMC3162473", "20384440"]}, {"Citation": "Arjomandi M, Balmes JR, Frampton MW, Bromberg P, Rich DQ, Stark P, et al. 2018. Respiratory responses to ozone exposure. MOSES (the Multicenter Ozone Study in oldEr Subjects). Am J Respir Crit Care Med 197:1319\u20131327; doi: 10.1164/rccm.201708-1613OC.", "ArticleIdList": ["29232153"]}, {"Citation": "Atkinson RW, Butland BK, Dimitroulopoulou C, Heal MR, Stedman JR, Carslaw N, et al. 2016. Long-term exposure to ambient ozone and mortality: A quantitative systematic review and meta-analysis of evidence from cohort studies. BMJ Open 6(2):e009493; doi:10.1136/bmjopen-2015-009493 [Online 23 February 2016].", "ArticleIdList": ["PMC4769417", "26908518"]}, {"Citation": "Balmes JR. 2019. Long-Term Exposure to Ozone and Cardiopulmonary Mortality: Epidemiology Strikes Again. Am J Respir Crit Care Med 200(8):958\u2013959. doi:10.1164/rccm.201906-1105ED.", "ArticleIdList": ["PMC6794103", "31185178"]}, {"Citation": "Balmes JR, Arjomandi M, Bromberg PA, Costantini MG, Dagincourt N, Hazucha MJ, et al. 2019. Ozone effects on blood biomarkers of systemic inflammation, oxidative stress, endothelial function, and thrombosis: The Multicenter Ozone Study in oldEr Subjects (MOSES). PLoS One. 14(9):e0222601; doi: 10.1371/journal.pone.0222601.", "ArticleIdList": ["PMC6760801", "31553765"]}, {"Citation": "Balmes JR, Chen LL, Scannell C, Tager I, Christian D, Hearne PQ, et al. 1996. Ozone-induced decrements in FEV1 and FVC do not correlate with measures of inflammation. Am J Respir Crit Care Med 153(3):904\u2013909.", "ArticleIdList": ["8630571"]}, {"Citation": "Brauer M, Brook JR, Christidis T, Chu Y, Crouse D, Erickson A, et al. 2019. Mortality\u2013Air Pollution Associations in Low-Exposure Environments (MAPLE): Phase 1. Research Report 203. Boston, MA:Health Effects Institute.", "ArticleIdList": ["PMC7334864", "31909580"]}, {"Citation": "Bromberg PA. 2016. Mechanisms of the acute effects of inhaled ozone in humans. Biochim Biophys Acta 1860(12):2771\u20132781; doi:10.1016/j.bbagen.2016.07.015 [Online 21 July 2016].", "ArticleIdList": ["27451958"]}, {"Citation": "Buteau S, Goldberg MS. 2016. A structured review of panel studies used to investigate associations between ambient air pollution and heart rate variability. Environ Res 148:207\u2013247; doi:10.1016/j.envres.2016.03.013 [Online 14 April 2016].", "ArticleIdList": ["27085495"]}, {"Citation": "Cakmak S, Hebbern C, Vanos J, Crouse DL, Burnett R. 2016. Ozone exposure and cardiovascular-related mortality in the Canadian Census Health and Environment Cohort (CANCHEC) by spatial synoptic classification zone. Environ Pollut 214:589\u2013599; doi:10.1016/j.envpol.2016.04.067 [Online 29 April 2016].", "ArticleIdList": ["27131819"]}, {"Citation": "Chang HH, Zhou J, Fuentes M. 2010. Impact of climate change on ambient ozone level and mortality in southeastern United States. Int J Environ Res Public Health 7(7):2866\u20132880; doi:10.3390/ijerph7072866 [Online 14 July 2010].", "ArticleIdList": ["PMC2922733", "20717546"]}, {"Citation": "Coogan PF, White LF, Yu J, Brook RD, Burnett RT, Marshall JD, et al. 2017. Long-term exposure to NO2 and ozone and hypertension incidence in the black women\u2019s health study. Am J Hypertens 30:367\u2013372; doi:10.1093/ajh/hpw168[Online 1 April 2017].", "ArticleIdList": ["PMC5861564", "28096146"]}, {"Citation": "Danesh Yazdi M, Wang Y, Di Q, Zanobetti A, Schwartz J. 2019. Long-term exposure to PM2.5 and ozone and hospital admissions of Medicare participants in the southeast USA. Environ Int 130:104879; doi:10.1016/j.envint.2019.05.073.", "ArticleIdList": ["PMC7751740", "31238267"]}, {"Citation": "Devlin RB, Duncan KE, Jardim M, Schmitt MT, Rappold AG, Diaz-Sanchez D. 2012. Controlled exposure of healthy young volunteers to ozone causes cardiovascular effects. Circulation 126:104\u2013111; doi:10.1161/CIRCULATIONAHA.112.094359 [Online 25 June 2012].", "ArticleIdList": ["22732313"]}, {"Citation": "Dominici F, Schwartz J, Di Q, Braun D, Choirat C, Zanobetti A. 2019. Assessing Adverse Health Effects of Long-Term Exposure to Low Levels of Ambient Air Pollution: Phase 1. Research Report 200. Boston, MA:Health Effects Institute.", "ArticleIdList": ["PMC7300216", "31909579"]}, {"Citation": "Fakhri AA, Ilic LM, Wellenius GA, Urch B, Silverman F, Gold DR, et al. 2009. Autonomic effects of controlled fine particulate exposure in young healthy adults: Effect modification by ozone. Environ Health Perspect 117(8):1287\u20131292; doi:10.1289/ehp.0900541 [Online 24 April 2009].", "ArticleIdList": ["PMC2721874", "19672410"]}, {"Citation": "Fann N, Nolte CG, Dolwick P, Spero TL, Brown AC, Phillips S, et al. 2015. The geographic distribution and economic value of climate change-related ozone health impacts in the United States in 2030. J Air Waste Manag Assoc 65(5):570\u2013580; doi:10.1080/10962247.2014.996270 [Online May 2015].", "ArticleIdList": ["25947315"]}, {"Citation": "Frampton MW, Balmes JR, Bromberg PA, Stark P, Arjomandi M, Hazucha MJ, et al. 2017. Multicenter Ozone Study in oldEr Subjects (MOSES): Part 1. Effects of Exposure to Low Concentrations of Ozone on Respiratory and Cardiovascular Outcomes. Research Report 192, Part 1 Boston, MA:Health Effects Institute.", "ArticleIdList": ["PMC7266375", "31898880"]}, {"Citation": "Gong H, Jr, Wong R, Sarma RJ, Linn WS, Sullivan ED, Shamoo DA, et al. 1998. Cardiovascular effects of ozone exposure in human volunteers. Am J Respir Crit Care Med 158(2):538\u2013546.", "ArticleIdList": ["9700133"]}, {"Citation": "Health Effects Institute. 2019. \nState of Global Air. Available:  www.stateofglobalair.org."}, {"Citation": "Institute of Health Metrics and Evaluation. 2019. \nGlobal Burden of Disease. Available at:  www.healthdata.org/gbd."}, {"Citation": "Ito K, De Leon SF, Lippmann M. 2005. Associations between ozone and daily mortality: Analysis and meta-analysis. Epidemiology 16(4):446\u2013457.", "ArticleIdList": ["15951662"]}, {"Citation": "Jerrett M, Brook R, White LF, Burnett RT, Yu J, Su J, et al. 2017. Ambient ozone and incident diabetes: A prospective analysis in a large cohort of African American women. Environ Int 102:42\u201347; doi:10.1016/j.envint.2016.12.011 [Online 30 January 2017].", "ArticleIdList": ["PMC5542012", "28153529"]}, {"Citation": "Karlsson PE, Klingberg J, Engardt M, Andersson C, Langner J, Karlsson GP, et al. 2017. Past, present and future concentrations of ground-level ozone and potential impacts on ecosystems and human health in northern Europe. Sci Total Environ 576:22\u201335; doi:10.1016/j.scitotenv.2016.10.061 [Online 22 October 2016].", "ArticleIdList": ["27780097"]}, {"Citation": "Kim CS, Alexis NE, Rappold AG, Kehrl H, Hazucha MJ, Lay JC, et al. 2011. Lung function and inflammatory responses in healthy young adults exposed to 0.06 ppm ozone for 6.6 hours. Am J Respir Crit Care Med 183(9):1215\u20131221; doi:10.1164/rccm.201011-1813OC [Online 7 January 2011].", "ArticleIdList": ["PMC3114053", "21216881"]}, {"Citation": "Lim CC, Hayes RB, Ahn J, Shao Y, Silverman DT, Jones RR, et al. 2019. Long-term exposure to ozone and cause-specific mortality risk in the United States. Am J Respir Crit Care Med 200(8):1022\u20131031; doi:10.1164/rccm.201806-1161OC.", "ArticleIdList": ["PMC6794108", "31051079"]}, {"Citation": "National Academies of Sciences, Engineering and Medicine. 2017. Controlled Human Inhalation-Exposure Studies at EPA. Washington, DC: The National Academies Press; doi:10.17226/24618.", "ArticleIdList": ["28617568"]}, {"Citation": "Olstrup H, Johansson C, Forsberg B, \u00c5str\u00f6m C. 2019. Association between mortality and short-term exposure to particles, ozone and nitrogen dioxide in Stockholm, Sweden. Int J Environ Res Public Health 16(6):E1028; doi:10.3390/ijerph16061028.", "ArticleIdList": ["PMC6466204", "30901873"]}, {"Citation": "Paulin LM, Gassett AJ, Alexis NE, Kirwa K, Kanner RE, Peters S., et al. 2019. Association of long-term ambient ozone exposure with respiratory morbidity in smokers. JAMA Intern Med 180(1):106\u2013115; doi:10.1001/jamainternmed.2019.5498.", "ArticleIdList": ["PMC6902160", "31816012"]}, {"Citation": "Peng RD, Samoli E, Pham L, Dominici F, Touloumi G, Ramsay T, et al. 2013. Acute effects of ambient ozone on mortality in Europe and North America: Results from the APHENA study. Air Qual Atmos Health 6(2):445\u2013453.", "ArticleIdList": ["PMC3668792", "23734168"]}, {"Citation": "Pryor WA. 1992. How far does ozone penetrate into the pulmonary air/tissue boundary before it reacts? Free Radic Biol Med 12(1):83\u201388.", "ArticleIdList": ["1537573"]}, {"Citation": "Ramanathan G, Yin F, Speck M, Tseng CH, Brook JR, Silverman F, et al. 2016. Effects of urban fine particulate matter and ozone on HDL functionality. Part Fibre Toxicol 13(1):26; doi:10.1186/s12989-016-0139-3 [Online 24 May 2016].", "ArticleIdList": ["PMC4879751", "27221567"]}, {"Citation": "Raza A, Dahlquist M, Jonsson M, Hollenberg J, Svensson L, Lind T, et al. 2019. Ozone and cardiac arrest: The role of previous hospitalizations. Environ Pollut 245:1\u20138; doi:10.1016/j.envpol.2018.10.042.", "ArticleIdList": ["30399483"]}, {"Citation": "Rhee J, Dominici F, Zanobetti A, Schwartz J, Wang Y, Di Q., et al. 2019. Impact of long-term exposures to ambient PM2.5 and ozone on ARDS risk for older adults in the United States. Chest 156(1):71\u201379; doi:10.1016/j.chest.2019.03.017.", "ArticleIdList": ["PMC6607425", "30926395"]}, {"Citation": "Rich DQ, Balmes JR, Frampton MW, Zareba W, Stark P, Arjomandi M, et al. 2018. Cardiovascular function and ozone exposure: The Multicenter Ozone Study in oldEr Subjects (MOSES). Environ Int 119:193\u2013202; doi:10.1016/j.envint.2018.06.014.", "ArticleIdList": ["29980042"]}, {"Citation": "Rich DQ, Thurston SW, Balmes JR, Bromberg PA, Arjomandi M, Hazucha MJ, et al. 2020. Do ambient ozone or other pollutants modify effects of controlled ozone exposure on pulmonary function? Ann Am Thorac Soc In press.", "ArticleIdList": ["32125874"]}, {"Citation": "Schwartz J. 2000. The distributed lag between air pollution and daily deaths. Epidemiology 11(3):320\u2013326.", "ArticleIdList": ["10784251"]}, {"Citation": "Sivagangabalan G, Spears D, Masse S, Urch B, Brook RD, Silverman F, et al. 2011. The effect of air pollution on spatial dispersion of myocardial repolarization in healthy human volunteers. J Am Coll Cardiol 57(2):198\u2013206; doi:10.1016/j.jacc.2010.08.625 [Online 11 January 2011].", "ArticleIdList": ["21211691"]}, {"Citation": "Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. 1996. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Eur Heart J 17(3):354\u2013381.", "ArticleIdList": ["8737210"]}, {"Citation": "Torres A, Utell MJ, Morow PE, Voter KZ, Whitin JC, Cox C, et al. 1997. Airway inflammation in smokers and non-smokers with varying responsiveness to ozone. Am J Respir Crit Care Med 156(3 Pt 1):728\u2013736.", "ArticleIdList": ["9309986"]}, {"Citation": "Turner MC, Jerrett M, Pope CA, 3rd, Krewski D, Gapstur SM, Diver WR, et al. 2016. Long-term ozone exposure and mortality in a large prospective study. Am J Respir Crit Care Med 193(10):1134\u20131142; doi:10.1164/rccm.201508-1633OC [Online 15 May 2016].", "ArticleIdList": ["PMC4872664", "26680605"]}, {"Citation": "U.S. Environmental Protection Agency. 2013. Integrated Science Assessment (ISA) for Ozone and Related Photochemical Oxidants (Final Report, Feb 2013). EPA/600/R-10/076F. Washington, DC:U.S. Environmental Protection Agency."}, {"Citation": "U.S. Environmental Protection Agency. 2019. Integrated Science Assessment (ISA) for Ozone and Related Photochemical Oxidants, External Review Draft. EPA/600/R-19/093, September 2019. Research Triangle Park, NC:U.S. Environmental Protection Agency, Office of Research and Development, National Center for Environmental Assessment RTP Division."}, {"Citation": "Wang M, Sampson PD, Sheppard LE, Stein JH, Vedal S, Kaufman JD. 2019. Long-term exposure to ambient ozone and progression of subclinical arterial disease: The Multi-Ethnic Study of Atherosclerosis and Air Pollution. Environ Health Perspect 127(5):57001; doi:10.1289/EHP3325.", "ArticleIdList": ["PMC6791411", "31063398"]}, {"Citation": "Zanobetti A, Schwartz J. 2006. Air pollution and emergency admissions in Boston, MA. J Epidemiol Comm Health 60:890\u2013895.", "ArticleIdList": ["PMC2566060", "16973538"]}, {"Citation": "Zhang S, Breitner S, Cascio WE, Devlin RB, Neas LM, Diaz-Sanchez D., et al. 2018. Short-term effects of fine particulate matter and ozone on the cardiac conduction system in patients undergoing cardiac catheterization. Part Fibre Toxicol 15(1):38; doi:10.1186/s12989-018-0275-z.", "ArticleIdList": ["PMC6180522", "30305173"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "4", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "4", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "10", "Day": "27", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "3", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["32239870", "PMC7325421", "Res Rep Health Eff Inst. 2020 Mar;(192, Pt 2):1-90."]}}], "PubmedBookArticle": []}